Kiai Parsa's Form 4 filing
Medifast Inc (MED) · filed Aug 21, 2026
- Accession no.
- 0001213900-26-092479
- Filed
- Aug 21, 2026, 12:35 PM ET
- Trade date
- Aug 19-20, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $842.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kiai ParsaCIK 0001766850 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Stock | PPurchaseAcquired | +28,538 | $11.66 | +$332,684.59 | 619,331 | Indirect | |
| Aug 19, 2026 | Common Stock | PPurchaseAcquired | +799 | $11.66 | +$9,314.42 | 17,802 | Indirect | |
| Aug 20, 2026 | Common Stock | PPurchaseAcquired | +41,975 | $11.60 | +$487,065.31 | 661,306 | Indirect | |
| Aug 20, 2026 | Common Stock | PPurchaseAcquired | +1,175 | $11.60 | +$13,634.35 | 18,977 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.